One pill to rule cholesterol? new combo drug tested

NCT ID NCT07182383

Completed Knowledge-focused Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a single pill containing three cholesterol-lowering drugs (bempedoic acid, ezetimibe, and rosuvastatin) works the same as taking them separately. Fifty-eight healthy adults each received both the combination pill and the individual pills at different times. Researchers measured drug levels in the blood to see if the combination pill delivers the same amount of medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bempedoic acid, ezetimibe, and rosuvastatin
What this could lead to: If successful, this could lead to a simpler, single-pill option for lowering cholesterol, making it easier for patients to stick with their treatment.
What could go wrong: This is an early-stage study in healthy people, not patients. It only checks if the combined pill is absorbed similarly to separate pills, not if it actually reduces heart risks or is safe long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY SUBJECTS

Contacts and locations

Locations

Research Site

Porto, 4250-449, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.